| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 1/6 |
| Financial Health | 4/6 |
| Dividends | 2/6 |
Anhui Huaren Health Pharmaceutical Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥11.48 |
| 52 Week High | CN¥26.65 |
| 52 Week Low | CN¥9.62 |
| Beta | 0 |
| 11 Month Change | 12.99% |
| 3 Month Change | -10.31% |
| 1 Year Change | -33.06% |
| 33 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -54.64% |
Recent News & Updates
Shareholder Returns
| 301408 | CN Consumer Retailing | CN Market | |
|---|---|---|---|
| 7D | 7.2% | 0.6% | 0.8% |
| 1Y | -33.1% | -40.1% | -21.0% |
Return vs Industry: 301408 exceeded the CN Consumer Retailing industry which returned -40.1% over the past year.
Return vs Market: 301408 underperformed the CN Market which returned -21% over the past year.
Price Volatility
| 301408 volatility | |
|---|---|
| 301408 Average Weekly Movement | 4.5% |
| Consumer Retailing Industry Average Movement | 5.1% |
| Market Average Movement | 5.7% |
| 10% most volatile stocks in CN Market | 8.9% |
| 10% least volatile stocks in CN Market | 3.9% |
Stable Share Price: 301408 has not had significant price volatility in the past 3 months.
Volatility Over Time: 301408's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2001 | 6,873 | n/a | www.hrjkjt.com |
Anhui Huaren Health Pharmaceutical Co., Ltd. operates in the medical and healthcare industry. It offers products for oral and throat, nourishing, bruises bones disease, endocrine, heat-clearing, respiratory system, cold, anti-allergic, ophthalmology, antipyretic, analgesic, rheumatism pediatrics, skin, and gynecology, as well as provides vitamins and minerals, detoxifying, and antibacterial and anti-inflammatory products.
Anhui Huaren Health Pharmaceutical Co., Ltd. Fundamentals Summary
| 301408 fundamental statistics | |
|---|---|
| Market cap | CN¥4.41b |
| Earnings (TTM) | CN¥132.96m |
| Revenue (TTM) | CN¥4.06b |
34.5x
P/E Ratio1.1x
P/S RatioIs 301408 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 301408 income statement (TTM) | |
|---|---|
| Revenue | CN¥4.06b |
| Cost of Revenue | CN¥2.81b |
| Gross Profit | CN¥1.24b |
| Other Expenses | CN¥1.11b |
| Earnings | CN¥132.96m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
Aug 29, 2024
| Earnings per share (EPS) | 0.33 |
| Gross Margin | 30.65% |
| Net Profit Margin | 3.28% |
| Debt/Equity Ratio | 53.4% |
How did 301408 perform over the long term?
See historical performance and comparison